Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasja Klioueva

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Handbook of Clinical Neurology|October 9, 2017
Banking brain tissue for researchNatasja Klioueva, Jasper Bovenberg, Inge Huitinga
Neuroscience Bulletin|November 4, 2018
Legal and Ethical Issues in Brain BankingInge Huitinga, Mignon de Goeij, Natasja Klioueva
The Lancet. Neurology|October 1, 2013
Brain banking for neurological disordersNeshika Samarasekera, Rustam Al-Shahi Salman, Inge Huitinga, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Handbook of Clinical Neurology|October 9, 2017
Banking brain tissue for researchNatasja Klioueva, Jasper Bovenberg, Inge Huitinga
Neuroscience Bulletin|November 4, 2018
Legal and Ethical Issues in Brain BankingInge Huitinga, Mignon de Goeij, Natasja Klioueva
The Lancet. Neurology|October 1, 2013
Brain banking for neurological disordersNeshika Samarasekera, Rustam Al-Shahi Salman, Inge Huitinga, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
Pageof 1